三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
Vepdegestrantvs氟维司群在HR+/HER2-BC(全人群)的PFS数据
Vepdegestrantvs氟维司群在HR+/HER2-BC(全人群)的PFS数据
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:816KB
图片尺寸:1939*1223
同报告图片
/
4
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
所属报告:
医药生物行业专题:寻找未被满足的临床需求(3)HR+ 、HER2~ BC多种新机制药物有望延长免化疗生存期-250807(63页).pdf
打包全文图表
相关数据
依沃西为全球首个在三期临床中头对头击败K药的新药,PFS强阳性(HR=0.51)
收藏
行业数据
2026-03-31
原图定位
查看详情
HARMONi-6试验主要终点:依沃西+化疗较对照臂PFS提升4.2个月(HR=0.60)
收藏
行业数据
2026-03-31
原图定位
查看详情
CARTITUDE-4 TME: Patients With Shorter PFS (≤18M) and Patients With More pLOT had a More Suppressive TME
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
收藏
行业数据
2026-03-11
原图定位
查看详情
CARTITUDE-4: PFS and OS in Patients With Standard-Risk Cytogenetics (As-Treated)
fCDnu4TliKsgfCAzMOS4quaciOaXoOi/m+WxleeUn+WtmOeOh++8iFBGUywgJe+8iSB8IDMw5Liq5pyI5oC755Sf5a2Y546H77yIT1MsICXvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCBDQVJUSVRVREUgLSA0IOagh+WHhumjjumZqSB8IDgwLjUgfCA4Ny4zIHwKfCBDQVJUSVRVREUgLSA0IOagh+WHhumjjumZqSArIGdhaW4vYW1wKDFxKSB8IDcxLjcgfCA4Ni4xIHwKCui1hOaWmeadpea6kO+8mlBBUlRJVFVERSAtIDQg56CU56m277yI5qCH5YeG6aOO6Zmp57uG6IOe6YGX5Lyg5a2m5oKj6ICFIEFzIC0gVHJlYXRlZCDliIbmnpDvvInmlbDmja4=
收藏
行业数据
2026-03-11
原图定位
查看详情
Figure 3: PFS (A) and OS (B)
fCDmjIfmoIcgICAgICAgfCAzNuS4quaciOeOhyB8IDk1JSDnva7kv6HljLrpl7QgfAp8LS0tLS0tLS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS18CnwgUEZTICAgICAgICB8IDkzLjglICAgIHwgNjMuMuKAkzk5LjEgICAgfAp8IE9TICAgICAgICAgfCA5My44JSAgICB8IDYzLjLigJM5OS4xICAgIHwKCui1hOaWmeadpea6kO+8muWbvueJh+S4reKAnFJlc3VsdHPigJ3mnb/lnZflj4pGaWd1cmUgM++8iFBGUyAoQSkg5ZKMIE9TIChCKe+8ieWGheWuueOAgg==
收藏
行业数据
2026-03-11
原图定位
查看详情
全球TROP2/HER3靶点创新管线临床布局(截至2025.12)
PHRhYmxlPgogICAgPHRoZWFkPgogICAgICAgIDx0cj4KICAgICAgICAgICAgYGBgaHRtbAo8dGg+6I2v5ZOB5ZCN56ewPC90aD4KICAgICAgICAgICAgPHRoPueglOWPkeacuuaehDwvdGg+CiAgICAgICAgICAgIDx0aD7pnbbngrk8L3RoPgogICAgICAgICAgICA8dGg+5L2c55So5py65Yi2PC90aD4KICAgICAgICAgICAgPHRoPueWvueXhTwvdGg+CiAgICAgICAgICAgIDx0aD7lhajnkIPmnIDpq5jnoJTlj5HpmLbmrrU8L3RoPgogICAgICAgICAgICA8dGg+5YWo55CD5pyA6auY56CU5Y+R6Zi25q615byA5aeL5pel5pyfPC90aD4KICAgICAgICAgICAgPHRoPuS4reWbveacgOmrmOeglOWPkemYtuautTwvdGg+CiAgICAgICAgICAgIDx0aD7kuK3lm73mnIDpq5jnoJTlj5HpmLbmrrXlvIDlp4vml6XmnJ88L3RoPgogICAgICAgIDwvdHI+CiAgICA8L3RoZWFkPgogICAgPHRib2R5PgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkIHJvd3NwYW49IjUiPkpTS04tMDE2PC90ZD4KICAgICAgICAgICAgPHRkIHJvd3NwYW49IjUiPuW6t+WugeadsOeRnjwvdGQ+CiAgICAgICAgICAgIDx0ZCByb3dzcGFuPSI1Ij5IRVIzO1RST1AyPC90ZD4KICAgICAgICAgICAgPHRkIHJvd3NwYW49IjUiPuWPjOaKl+WBtuiBlOeJqSBBREM8L3RkPgogICAgICAgICAgICA8dGQ+6Z2e5bCP57uG6IOe6IK655mMPC90ZD4KICAgICAgICAgICAgPHRkPuKFoeacn+S4tOW6ijwvdGQ+CiAgICAgICAgICAgIDx0ZD4yMDI0LTEyLTIwPC90ZD4KICAgICAgICAgICAgPHRkPuKFoeacn+S4tOW6ijwvdGQ+CiAgICAgICAgICAgIDx0ZD4yMDI0LTEyLTIwPC90ZD4KICAgICAgICA8L3RyPgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPumjn+euoeiFuueZjDwvdGQ+CiAgICAgICAgICAgIDx0ZD7ihaHmnJ/kuLTluoo8L3RkPgogICAgICAgICAgICA8dGQ+MjAyNS0wNC0yNTwvdGQ+CiAgICAgICAgICAgIDx0ZD7ihaHmnJ/kuLTluoo8L3RkPgogICAgICAgICAgICA8dGQ+MjAyNS0wNC0yNTwvdGQ+CiAgICAgICAgPC90cj4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD7og4PnmYzvvJvog4Ppo5/nrqHkuqTnlYzlpITnmYw8L3RkPgogICAgICAgICAgICA8dGQ+4oWh5pyf5Li05bqKPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjUtMDQtMjU8L3RkPgogICAgICAgICAgICA8dGQ+4oWh5pyf5Li05bqKPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjUtMDQtMjU8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+5Lmz6IW655mMPC90ZD4KICAgICAgICAgICAgPHRkPuKFoC/ihaHmnJ/kuLTluoo8L3RkPgogICAgICAgICAgICA8dGQ+MjAyNS0wNC0yNDwvdGQ+CiAgICAgICAgICAgIDx0ZD7ihaAv4oWh5pyf5Li05bqKPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjUtMDQtMjQ8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+5a6e5L2T55ikPC90ZD4KICAgICAgICAgICAgPHRkPuKFoOacn+S4tOW6ijwvdGQ+CiAgICAgICAgICAgIDx0ZD4yMDI0LTA0LTI4PC90ZD4KICAgICAgICAgICAgPHRkPuKFoOacn+S4tOW6ijwvdGQ+CiAgICAgICAgICAgIDx0ZD4yMDI0LTA0LTI4PC90ZD4KICAgICAgICA8L3RyPgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPk9MSS0wMTAyPC90ZD4KICAgICAgICAgICAgPHRkPk9saWdvbjwvdGQ+CiAgICAgICAgICAgIDx0ZD5IRVIzO1RST1AyPC90ZD4KICAgICAgICAgICAgPHRkPnNpUk5B77yb6YCC6YWN5L2T5YG26IGU6I2v54mpIEFwREM8L3RkPgogICAgICAgICAgICA8dGQ+6Z2e5bCP57uG6IOe6IK655mM77yb5Lmz6IW655mMPC90ZD4KICAgICAgICAgICAgPHRkPuS4tOW6iuWJjTwvdGQ+CiAgICAgICAgICAgIDx0ZD4tPC90ZD4KICAgICAgICAgICAgPHRkPuS4tOW6iuWJjTwvdGQ+CiAgICAgICAgICAgIDx0ZD4tPC90ZD4KICAgICAgICA8L3RyPgogICAgPC90Ym9keT4KPC90YWJsZT4KCui1hOaWmeadpea6kO+8muWMu+iNr+mtlOaWue+8jOilv+mDqOivgeWIuOeglOWPkeS4reW/gwpgYGA=
收藏
行业数据
2025-12-31
原图定位
查看详情
国内抗HER2+肿瘤市场规模分析
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
收藏
市场规模
2025-12-31
原图定位
查看详情
HER2+不可切除局部晚期/转移性胃/胃食管结合部癌治疗格局
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
收藏
竞争格局
2025-12-31
原图定位
查看详情
T-DXd对HER2-lowBC的全人群PFS
fCDpobnnm64gICAgICAgICAgICAgICAgfCBULURYZCAgICAgICB8IFRQQyAgICAgICAgIHwKfC0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS18Cnwg5Lit5L2N5peg6L+b5bGV55Sf5a2Y5pyfKG1vKSB8IDkuOSAgICAgICAgIHwgNS4xICAgICAgICAgfAp8IOmjjumZqeavlChIYXphcmQgUmF0aW8pIHwgMC41MCAgICAgICAgfCAtICAgICAgICAgICB8CnwgOTUl572u5L+h5Yy66Ze0KDk1JSBDSSkgIHwgMC40MCAtIDAuNjMgfCAtICAgICAgICAgICB8CnwgUOWAvCAgICAgICAgICAgICAgICAgfCA8IDAuMDAwMSAgICB8IC0gICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muesrOS4gOS4ieWFse+8jEFTQ08gMjAyMu+8jOeIseW7uuivgeWIuOeglOeptuaJgA==
收藏
行业数据
2025-11-24
原图定位
查看详情
国产HER2ADC联合PD-1为一线尿路上皮癌患者提供新的优选方案
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
收藏
行业数据
2025-10-24
原图定位
查看详情
替康类毒素HER2ADC美国临床试验进展对比
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
收藏
行业数据
2025-10-24
原图定位
查看详情
Ivonescimab国内临床,PFS显著优于K药
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
收藏
行业数据
2025-10-24
原图定位
查看详情
中国HER+/HER2低表达BC治疗标准:HER2ADC治疗地位持续上升中
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
收藏
行业数据
2025-10-23
原图定位
查看详情
美国HER+/HER2低表达BC治疗标准:HER2ADC治疗地位持续上升中
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
收藏
行业数据
2025-10-23
原图定位
查看详情
维迪西妥单抗联合免疫奠定在HER2表达mUC患者晚期一线治疗的标准治疗地位(非头对头)
fCDoja/nianlkI3np7AgICAgICAgICB8IOe7tOi/quilv+WmpSAgICAgICB8IDlNVzI4MjEgICAgICAgICAgICAgICAgfCBFbmZvcnR1bWFiIFZlZG90aW4gICAgIHwKfC0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18Cnwg5byA5Y+R5YWs5Y+4ICAgICAgICAgfCDojaPmmIznlJ/niakgICAgICAgfCDov4jlqIHnlJ/niakgICAgICAgICAgICAgICB8IEFzdGVsbGFzICAgICAgICAgICAgICAgfAp8IOS9nOeUqOacuuWItiAgICAgICAgIHwgSEVSMiBBREMgICAgICAgfCBOZWN0aW4tNCBBREMgICAgICAgICAgIHwgTmVjdGluLTQgQURDICAgICAgICAgICB8Cnwg5Li05bqK5Luj5Y+3ICAgICAgICAgfCBSQzQ4LUMwMTYgICAgICB8IE5DVDA2MDc5MTEyICAgICAgICAgICAgfCBFVi0zMDIgICAgICAgICAgICAgICAgIHwKfCDkuLTluorojIPlm7QgICAgICAgICB8IOS4reWbvSAgICAgICAgICAgfCDkuK3lm70gICAgICAgICAgICAgICAgICAgfCDlhajnkIMgICAgICAgICAgICAgICAgICAgfAp8IOaVsOaNrumYtuautSAgICAgICAgIHwgSUlJICAgICAgICAgICAgfCBJYi9JSSAgICAgICAgICAgICAgICAgIHwgSUlJICAgICAgICAgICAgICAgICAgICB8Cnwg5byA5Y+R6Zi25q61ICAgICAgICAgfCBOREEgICAgICAgICAgICB8IElJSeacn++8iDI0LjA477yJICAgICAgICAgfCDkuIrluIIgICAgICAgICAgICAgICAgICAgfAp8IOayu+eWl+aWueahiCAgICAgICAgIHwg6IGU5ZCI54m555Ge5pmu5YipICAgfCDogZTlkIjnibnnkZ7mma7liKkgICAgICAgICAgIHwg6IGU5ZCIS+iNryAgICAgICAgICAgICAgICB8Cnwg5a+554Wn5pa55qGIICAgICAgICAgfCDljJbnlpcgICAgICAgICAgIHwgLSAgICAgICAgICAgICAgICAgICAgICB8IOWMlueWlyAgICAgICAgICAgICAgICAgICB8Cnwg5oKj6ICF5Z+657q/77yM5Lq6ICAgICB8IFVDPGJyPkhFUjLvvIgyK+aIljMr77yJNzcuNHZzLjc4LjAgfCBVQzxicj5OZWN0aW4tNCvvvIg4Mi41Je+8iTxicj5QRC1MMSvvvIgyMC4wJe+8iTxicj7ogp3ovaznp7sxNSUgfCBVQzxicj5QRC1MMSBDUFPiiaUxMO+8iDU4LjAl77yJPGJyPumhuumTguWPr+ayu++8iDU1LjIl77yJPGJyPuiCnei9rOenuzIyLjYlIHwKfCDmsrvnlpfnur/mlbAgICAgICAgICB8IDFMICAgICAgICAgICAgIHwgMUwgICAgICAgICAgICAgICAgICAgICB8IDFMICAgICAgICAgICAgICAgICAgICAgfAp8IOWPl+ivleaVsOmHjyAgICAgICAgIHwgNDg077yIMe+8mjHvvIkgICAgfCA0MCAgICAgICAgICAgICAgICAgICAgIHwgODg2KDE6MSkgICAgICAgICAgICAgICB8Cnwg55So5rOV55So6YePICAgICAgICAgfCAyLjAgbWcva2cgUTJXICB8IDEtMS4yNW1nL2tnIFEzVyAgICAgICAgfCAxLjI1IG1nL2tnIFEzVyAgICAgICAgIHwKfCDkuK3kvY3pmo/orr/ml7bpl7QsIG1vIHwgMTguMiAgICAgICAgICAgfCAxMC44ICAgICAgICAgICAgICAgICAgIHwgMjkuMSAgICAgICAgICAgICAgICAgICB8CnwgbVBGUywgbW8gICAgICAgICB8IDEzLjF2cy42LjU8YnI+SFI9MC4zNiB8IDEyLjXvvIjmnKrmiJDnhp/vvIkgICAgICAgICB8IDEyLjV2cy42LjM8YnI+SFI9MC40OCAgfAp8IG1PUywgbW8gICAgICAgICAgfCAzMS41dnMuMTYuOTxicj5IUj0wLjU0IHwgTkUgICAgICAgICAgICAgICAgICAgICB8IDMzLjh2cy4xNS45PGJyPkhSPTAuNTEgfAp8IG1Eb1IsIG1vICAgICAgICAgfCAxNC42dnMuNS42ICAgICB8IC0gICAgICAgICAgICAgICAgICAgICAgfCAyMy4zdnMuNy4wICAgICAgICAgICAgIHwKfCBPUlIsICUgICAgICAgICAgIHwgNzYuMXZzLjUwLjIgICAgfCA4Ny41ICAgICAgICAgICAgICAgICAgIHwgNjcuNXZzLjQ0LjIgICAgICAgICAgICB8CnwgR3JhZGXiiaUzIFRSQUVzLCAlIHwgNTUuMXZzLjg2LjkgICAgfCA0Mi4zMCUgICAgICAgICAgICAgICAgIHwgNTcuM3ZzLjY5LjUgICAgICAgICAgICB8CgrotYTmlpnmnaXmupDvvJoyMDI1RVNNT++8jGluc2lnaHTvvIzlm73ph5Hor4HliLjnoJTnqbbmiYA=
收藏
行业数据
2025-10-23
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
行业数据
原图定位
当前图表所属:
医药生物行业专题:寻找未被满足的临床需求(3)HR+ 、HER2~ BC多种新机制药物有望延长免化疗生存期-250807(63页).pdf
2025年 HR+_HER2-乳腺癌治疗行业报告:内分泌治疗新机制突破,CDK抑制剂升级趋势
获批上市的PI3K/AKT/mTOR通路靶向药
恒瑞医药HR+/HER2-BC临床布局
已获FDA批准上市的CDK4/6抑制剂
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》